Histologic outcomes in hepatitis C-infected patients with varying degrees of virologic response to interferon-based treatments

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Paul J PockrosAnna S F Lok

Abstract

Patients with chronic hepatitis C with partial virologic response or nonresponse to interferon-based therapies can experience treatment-related improvements in liver histology. This retrospective analysis assessed the histologic response to treatment in patients with varying degrees of virologic response (sustained virologic response [SVR], breakthrough, relapse, or nonresponse), time to hepatitis C virus (HCV) RNA undetectability, and duration of viral suppression. Patients (HCV genotypes 1-6) with baseline and follow-up liver biopsies from eight phase 2 to phase 4 interferon-based trials were analyzed. Blinded biopsies were evaluated by a single pathologist. Improvements or worsening of METAVIR necroinflammatory activity and fibrosis were defined as increase or decrease of ≥1 grading category from baseline to 24 weeks after end of treatment. A majority of the 1571 patients with paired biopsy data were white, male, with HCV genotype 1/4, baseline HCV RNA levels >800,000 IU/mL, and baseline alanine aminotransferase levels ≤3 × upper limit of the normal range; mean baseline activity and fibrosis scores were 1.8 and 1.7, respectively. Overall, 80% of patients received peginterferon alfa-2a monotherapy or peginterferon alfa-2a/rib...Continue Reading

References

Sep 26, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M L ShiffmanC T Garrett
Jul 1, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G T EversonK Witt
Dec 7, 2000·The New England Journal of Medicine·S ZeuzemM J Brunda
Dec 7, 2000·The New England Journal of Medicine·E J HeathcoteJ De Pamphilis
Feb 15, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·K R ReddyJ DePamphilis
Jul 20, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C S GrahamM J Koziel
Sep 27, 2002·The New England Journal of Medicine·Michael W FriedJian Yu
Mar 5, 2004·Annals of Internal Medicine·Stephanos J HadziyannisUNKNOWN PEGASYS International Study Group
Jun 9, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Lennox J JeffersK Rajender Reddy
Jul 9, 2004·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·R Todd StravitzRobert A Fisher
Jul 30, 2004·The New England Journal of Medicine·Raymond T ChungUNKNOWN AIDS Clinical Trials Group A5071 Study Team
Aug 8, 2006·Gastroenterology·Hari S ConjeevaramUNKNOWN Virahep-C Study Group
Oct 27, 2006·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Maribel Rodríguez-TorresAcisclo M Marxuach-Cuétara
Feb 28, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Paul J PockrosSima Faris-Young
Dec 20, 2007·AIDS·Mark S SulkowskiDavid L Thomas
Dec 5, 2008·The New England Journal of Medicine·Adrian M Di BisceglieUNKNOWN HALT-C Trial Investigators
Jan 16, 2009·The New England Journal of Medicine·Maribel Rodriguez-TorresUNKNOWN Latino Study Group
May 1, 2009·The New England Journal of Medicine·Renato Bertini Malgarini, Giuseppe Pimpinella

❮ Previous
Next ❯

Citations

Feb 15, 2011·Clinical Therapeutics·Elena VezaliMassimo Colombo
Mar 23, 2011·Current Opinion in Gastroenterology·Shari L Taylor, Salima Haque
Jun 13, 2014·Journal of Clinical Gastroenterology·Vignan ManneSammy Saab
Aug 27, 2013·Journal of Hepatology·Adriaan J van der MeerHarry L A Janssen
Jan 26, 2016·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Mei LuUNKNOWN Chronic Hepatitis Cohort Study Investigators
Apr 29, 2014·Liver International : Official Journal of the International Association for the Study of the Liver·Ehsaan AkhtarSammy Saab
Apr 20, 2014·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Tomasz PawlowskiTomasz Laskus
Dec 10, 2015·Journal of Gastroenterology and Hepatology·Adriaan J van der MeerHarry LA Janssen
Apr 28, 2018·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Neil D TheiseHong You
May 25, 2011·Expert Review of Vaccines·John HallidayEleanor Barnes
Jan 11, 2020·Clinical and Molecular Hepatology·UNKNOWN Korean Association for the Study of the Liver (KASL)
Dec 5, 2017·European Journal of Gastroenterology & Hepatology·Muhammad H BashirSalman Nusrat
Jun 23, 2020·Chinese Medical Journal·Ya-Meng SunHong You
Jun 9, 2012·The Medical Journal of Australia·Heather F GiddingGregory J Dore
Feb 28, 2015·Expert Review of Gastroenterology & Hepatology·Fabienne MarcellinUNKNOWN ANRS-VESPA2 Study Group
Jan 24, 2020·World Journal of Gastroenterology : WJG·Sudeep TanwarWilliam M Rosenberg
Jan 13, 2015·Expert Review of Gastroenterology & Hepatology·Adriaan J van der Meer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.